Erratum. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Teede, Helena; Misso, Marie; Costello, Michael; Dokras, Anuja; Laven, Joop; Moran, Lisa; Piltonen, Terhi; Norman, Robert J.

doi:10.1093/humrep/dey363

Cited by 219 publications

(458 citation statements)

References 0 publications

Supporting

Mentioning

414

Contrasting

Unclassified

Order By: Relevance

“…Higher circulating C-reactive protein, interleukin 6, and tumor necrosis factor alpha have been reported in PCOS which, through various mechanisms, can contribute to adipocyte dysfunction, insulin resistance, and type 2 diabetes [10,40]. Compared to women without PCOS, women with PCOS have higher free testosterone and ratio of free testosterone to free estradiol [41], and reproductive health issues including irregular menstrual periods and subfertility [7]. Similar to PCOS, asthma is proinflammatory [42].…”

Section: Discussionmentioning

confidence: 99%

“…Polycystic ovary syndrome (PCOS) is an endocrine disorder with a reported overall prevalence rate of 6% to 10% [1] based on the Rotterdam diagnostic criteria of two of three features, i.e., oligoor anovulation, hyperandrogenism (clinical or biochemical), and polycystic ovaries on ultrasound, after exclusion of other causes [2]. PCOS is associated with reproductive (hyperandrogenism, anovulation, infertility, and pregnancy complications) [3] and metabolic features (elevated prevalence of and risk factors for type 2 diabetes and cardiovascular disease) [4,5], along with psychological impact, such as increased risk of depression and anxiety [6] and impaired quality of life [7]. Insulin resistance is a key pathophysiological contributor to PCOS.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Association between Dietary Intake, Asthma, and PCOS in Women from the Australian Longitudinal Study on Women’s Health

Grieger

Hodge

Mishra

et al. 2020

JCM

View full text Add to dashboard Cite

Dietary intake potentially modifies the prevalence or severity of asthma. The prevalence of asthma is higher in women with polycystic ovary syndrome (PCOS); it is not known if diet confounds or modifies the association between asthma and PCOS. The aims of this study were: (i) To determine if the association of PCOS and asthma is independent of dietary pattern and (ii) to determine if dietary pattern modifies the association between PCOS and asthma. Women in this study were from the Australian Longitudinal Study on Women’s Health (ALSWH) cohort born between 1973 to 1978 and aged 18 to 23 years (n = 7382). Logistic regression was used to assess the association between PCOS and asthma, adjusting for the following: (i) Potential confounders identified a priori and (ii) dietary patterns (z-score) identified by principle component analysis. In the adjusted analysis, women with PCOS were more likely to have asthma than the women without PCOS (OR 1.35 and 95% CI, 1.02 and 1.78). This relationship was not altered by further adjustment for dietary patterns (non-core food, meats and takeaway, or Mediterranean-style pattern). In the interaction analysis, only the women consuming less than the median intake of non-core foods (i.e., lower intake of discretionary or unhealthy foods) and with PCOS were more likely to have asthma (OR 1.91 and 95% CI, 1.29 and 2.82). Dietary intake did not confound the relationship between PCOS and asthma. Other mechanistic pathways are likely responsible for the asthma and PCOS association, and further studies assessing factors such as oral contraceptive use and sex steroid hormones warrant investigation.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The Association between Dietary Intake, Asthma, and PCOS in Women from the Australian Longitudinal Study on Women’s Health

Grieger

Hodge

Mishra

et al. 2020

JCM

View full text Add to dashboard Cite

show abstract

“…Бесплодие встречается у 70-75 % женщин. избыточная масса тела и ожирение отмечаются у 22-65 % женщин с сПя [3,4]. У значительной части пациенток (36-40 %) с сПя имеется нарушение толерантности к глюкозе.…”

Section: Retrospective Analysis Of Pregnancies Resulted From Assistedunclassified

“…У значительной части пациенток (36-40 %) с сПя имеется нарушение толерантности к глюкозе. У женщин с сПя в позднем репродуктивном периоде нередко развиваются сахарный диабет 2-го типа, сердечно-сосудистые заболевания, гиперплазия эндометрия, рак эндометрия [4]. Метаанализ, проведенный r.s.…”

Section: Retrospective Analysis Of Pregnancies Resulted From Assistedunclassified

“…регулярная физическая активность при сд 2-го типа улучшает компенсацию углеводного обмена, помогает снизить и поддержать массу тела, уменьшить инсулинорезистентность, способствует снижению гипертриглицеридемии. Физические нагрузки подбирают индивидуально, с учетом возраста, осложнений сд, сопутствующих заболеваний [4]. из медикаментозных средств препаратом первой линии для лечения сд 2-го типа является метформин.…”

Section: Discussionunclassified

See 1 more Smart Citation

Retrospective analysis of pregnancies resulted from assisted reproductive technology in women with type 2 diabetes mellitus

et al. 2019

View full text Add to dashboard Cite

Hypothesis/aims of study. Type 2 diabetes mellitus (T2D) is one of the most widespread diseases in the world. The etiology of this disease is associated with genetic, age and ethnic factors. It is generally accepted that a sedentary lifestyle and obesity can cause T2D. This illness has serious complications that affect the women’s health and quality of life. It is well known that obesity and T2D are a common cause of anovulatory infertility in women of reproductive age. The number of T2D patients who are planning pregnancy by assisted reproductive technology (ART) has increased over the past 10 years. This study was aimed at investigating the effect of carbohydrate metabolism compensation in the preconception period on the outcomes of pregnancies resulted from in vitro fertilization (IVF) in T2DM women. Study design, materials, and methods. 51 T2D pregnancies after ART and their outcomes were analyzed retrospectively. Results. The age of the patients who applied to ART departments ranged from 27 to 46 years. The mean body mass index was 33.9 ± 6.5 kg/m2. The duration of infertility varied from 3 to 18 years. Infertility was caused by tubal occlusion in 17 cases, by anovulation in 16 cases, by male factor in 9 cases, by genital endometriosis in 7 cases, and by hypergonadotropic hypogonadism in 2 cases. One of the patients underwent IVF procedure twice in 4 years. All T2D patients received prepregnancy care including weight loss, diabetes compensation, diabetes complications treatment, and, if necessary, a transfer to insulin therapy and insulin treatment education for 1–2 months before entering into the IVF protocol. Angiotensin-converting enzyme inhibitors and statins should be stopped if they were prescribed in case of hypertension or dyslipidemia and other medications allowed during pregnancy should be started. 26 women (51%) did not take periconceptional multivitamin supplementation before IVF procedure. The level of glycated hemoglobin (HbA1c) in this group was 6.4 ± 0.5%. 25 patients (49%) underwent incomplete preparation for pregnancy before entering into the IVF protocol but not in full. An important stage of prepregnancy care was weight loss in women with overweight and obesity. The duration of a prepregnancy care program varied from 2 to 6 months and on average was 3.8 ± 1.7 months. The mean HbA1c level in this group was 5.8 ± 0.4%. All cases of IVF pregnancies in women with T2D resulted with live birth. The incidence of preeclampsia, cesarean section delivery, and preterm labor was lower in the group of women who had been given prepregnancy care. Conclusion. Proper prepregnancy care including weight loss, diabetes compensation, early start of insulin therapy, and diabetes complications treatment before conception is an effective method of preventing perinatal complications in women with T2D.

show abstract

Laser and Light-Based Therapies for Hirsutism Management in Women With Polycystic Ovarian Syndrome

Tan,

Coster,

Mousa

et al. 2024

JAMA Dermatol

Self Cite

View full text Add to dashboard Cite

ImportanceHirsutism represents a significant concern for women with polycystic ovary syndrome (PCOS), with deleterious psychological effects warranting acknowledgment and a clear imperative to provide effective management. To our knowledge, this is the first review to exclusively examine the effectiveness of laser and light-based therapies in addressing hirsutism in women with PCOS.ObjectiveTo synthesize the existing literature regarding the effectiveness of laser and light hair reduction therapies, either as stand-alone treatments or in combination with systemic agents, in treating hirsutism for women with PCOS.Evidence ReviewA systematic literature review was performed using MEDLINE, Embase, EMCARE, and CINAHL according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guidelines. Articles written in English, reporting on patients who met pre-established inclusion criteria were selected. Objective and subjectively measured outcomes relating to the effect of laser or light-based hair reduction therapies on hirsutism were abstracted. Heterogeneity among included studies precluded a meta-analysis, necessitating a narrative synthesis.FindingsSix studies reporting data on 423 individual patients with PCOS who underwent laser or light-based hair reduction therapies were included: 4 randomized clinical trials and 2 cohort studies. Alexandrite laser demonstrated significant improvements in hirsutism severity and psychological outcomes, particularly at high-fluence application. Alexandrite laser was also found to be more effective than intense pulsed light (IPL). The combination of diode laser with either metformin or combined oral contraceptive pill was superior to the application of diode laser alone, just as the addition of metformin to IPL demonstrated superior results to IPL treatment alone. Overall, most interventions were well tolerated. The overall certainty of evidence across all outcomes and comparisons was limited in part due to the observational nature of some studies.Conclusions and RelevanceThis systematic review highlights the potential of laser and light hair reduction therapies, both as stand-alone treatments and in combination with other pharmacological agents in PCOS. However, this review was limited by low certainty of the evidence, few studies evaluating effectiveness and safety in those with skin of color, and heterogeneity in outcome assessment. Future studies are needed to provide more robust evidence among diverse individuals with PCOS and hirsutism.

show abstract

Erratum. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Cited by 219 publications

References 0 publications

The Association between Dietary Intake, Asthma, and PCOS in Women from the Australian Longitudinal Study on Women’s Health

The Association between Dietary Intake, Asthma, and PCOS in Women from the Australian Longitudinal Study on Women’s Health

Retrospective analysis of pregnancies resulted from assisted reproductive technology in women with type 2 diabetes mellitus

Laser and Light-Based Therapies for Hirsutism Management in Women With Polycystic Ovarian Syndrome

Contact Info

Product

Resources

About